Меню
Идёт набор NCT06887829

Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial

Без фазы С лечением Osteoarthritis, Knee

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Low dose radiotherapy, Sham comparator.
Кому может быть актуально
Состояния в реестре: Osteoarthritis, Knee. Базовые параметры: 50 лет — 100 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

The Randomized Clinical Trial of Low-Dose Radiotherapy for Knee Osteoarthritis

Обзор

The primary aim of this study is to investigate whether low-dose radiotherapy is an effective treatment to reduce the pain of knee osteoarthritis. A secondary aim is to determine whether patients experience any more measurable side effects than those receiving sham treatments.

Подробное описание

This single center, single-blinded, sham-controlled randomized controlled trial will compare low dose radiation therapy and sham radiation therapy for knee osteoarthritis. Participants with symptomatic knee OA based on clinical and radiographic criteria will be randomized 1:1 to receive 0.5 Gy LDRT over 2 weeks ideally on a Monday-Wednesday-Friday three times each week for two weeks treatment course for a total of 3 Gray or identical sham treatment (an identical procedure without the radiation). Non-responders to the initial Low-Dose Radiotherapy (LDRT)/sham treatment will receive a second treatment course of 0.5 Gy Low-Dose Radiotherapy (LDRT) or sham repeat treatment course over 2 weeks x 6 depending on their randomization (treatment arm participants receiving a second treatment course and sham arm participants receiving a second course of identical sham treatments without radiation). Intermittent and Constant Osteoarthritis Pain (ICOAP) outcome scales will be emailed to all participants for completion at baseline and weekly for six months. The study will thus terminate after all participants have completed 6 months of time in the study.

Вмешательства

  • Лучевая терапия Low dose radiotherapy
    Participants will receive low dose radiotherapy (0.5 Gy) 3 times per week, for two weeks delivered via the X-Strahl Orthovoltage device.
  • Другое Sham comparator
    Participants will receive identical treatment 3 times per week, for two weeks delivered via the X-Strahl Orthovoltage device, without radiation.

Первичные конечные точки

  • Change in Area Under the Curve (AUC) of ICOAP Scores [Срок оценки: Baseline, 6 months]
  • Analgesic use frequency in treatment vs. sham participants [Срок оценки: 6 months]

Критерии участия

Критерии включения

  • • patient's primary care provider is at Mayo Clinic in Rochester, MN
  • age 50-100 years
  • ICOAP pain scale A1 at least moderate intensity or B6 at least moderate intensity
  • diagnosed with primary knee OA ICD-10 codes M17.x

o You have not had recurrent episodes of sudden onset of warmth, redness, or swelling of the affected knee

  • physical exam findings of medial or lateral joint line tenderness on palpation that is in the same location as the knee pain.
  • absence of primary knee pain in the pes anserine or hamstring or gastrocnemius, quadriceps, or patellar tendons on exam.
  • radiographic Kellgren-Lawrence grade 2-3 on 4-view knee x-rays taken within the last year ability to complete surveys electronically by email

Критерии исключения

  • • Kellgren-Lawrence grade 1 or 4
  • pregnancy or women 54 years and younger with potential for pregnancy (if they or their partner have not had tubal ligation, hysterectomy, or vasectomy)
  • history of ipsilateral intraarticular knee surgery
  • use of injected corticosteroids within 3 months or hyaluronans within 6 months or within 1 month if there was no sustained improvement post-injection of either corticosteroid or hyaluronan.
  • history of trauma to this knee in the last year that clearly caused the pain now present
  • history of RA, gout, pseudogout, hemarthroses (eg, hemophilic arthropathy) or other inflammatory arthritis involving this knee
  • history of symptomatic hip OA
  • history of psychosis, personality disorder, uncontrolled affective disorder
  • history of fibromyalgia
  • malignancy requiring active treatment current regular use of opiate analgesics, PRP, or acupuncture for the knees

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

США · 1 центр
  • Mayo Clinic — Rochester

Идентификаторы

NCT: NCT06887829 · 24-006759

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗